Use of cardiac output to improve measurement of input function in quantitative dynamic contrast-enhanced MRI

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 3, 2009, Pages 656-665

  Zhang, Jeff L ^a,b   Rusinek, Henry ^a   Bokacheva, Louisa ^a   Chen, Qun ^a   Storey, Pippa ^a   Lee, Vivian S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Arterial input function; Cardiac output; Dynamic contrast enhanced MRI

Indexed keywords

ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MEASUREMENT ERROR; MONTE CARLO METHOD; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RENOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARDIAC OUTPUT; COMPUTER SIMULATION; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; KIDNEY; KIDNEY NEOPLASMS; KINETICS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MONTE CARLO METHOD; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 69449084292     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21891     Document Type: Article

References (54)

1. Barrett T, Brechbiel M, Bernardo M, Choyke PL. MRI of tumor angiogenesis. J Magn Reson Imaging 2007;26:235-249.
2. Kiessling F, Morgenstern B, Zhang C. Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging. Curr Med Chem 2007;14:77-91. (Pubitemid 46050305)
3. Turnbull LW. Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer. NMR Biomed 2009;22:28-39.
4. Marcus CD, Ladam-Marcus V, Cucu C, Bouche O, Lucas L, Hoeffel C. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol 2008 (in press).
5. Lee VS, Rusinek H, Bokacheva L, et al. Renal function measurements from MR renography and a simplified multicompartmental model. Am J Physiol 2007;292:F1548-1559. (Pubitemid 46701882)
6. Zhang JL, Rusinek H, Bokacheva L, et al. Functional assessment of the kidney from magnetic resonance and computed tomography renography: impulse retention approach to a multicompartment model. Magn Reson Med 2008;59:278-288. (Pubitemid 351220091)
7. Hackstein N, Kooijman H, Tomaselli S, Rau WS. Glomerular filtration rate measured using the Patlak plot technique and contrast-enhanced dynamic MRI with different amounts of gadolinium-DTPA. J Magn Reson Imaging 2005;22:406-414. (Pubitemid 41298329)
8. Roberts C, Buckley DL, Parker GJ. Comparison of errors associated with single- and multi-bolus injection protocols in low-temporal-resolution dynamic contrast-enhanced tracer kinetic analysis. Magn Reson Med 2006;56:611-619. (Pubitemid 44338880)
9. Wang Y, Huang W, Panicek DM, Schwartz LH, Koutcher JA. Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data. Magn Reson Med 2008;59:1183-1189. (Pubitemid 351590533)
10. Peeters F, Annet L, Hermoye L, Van Beers BE. Inflow correction of hepatic perfusion measurements using T1-weighted, fast gradient-echo, contrast-enhanced MRI. Magn Reson Med 2004;51:710-717. (Pubitemid 38420447)
11. Bokacheva L, Rusinek H, Chen Q, et al. Quantitative determination of Gd-DTPA concentration in T(1)-weighted MR renography studies. Magn Reson Med 2007;57:1012-1018.
12. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002; 47:135-142. (Pubitemid 34019702)
13. Ivancevic MK, Zimine I, Montet X, et al. Inflow effect correction in fast gradient-echo perfusion imaging. Magn Reson Med 2003;50: 885-891. (Pubitemid 37356567)
14. Heilmann M, Walczak C, Vautier J, et al. Simultaneous dynamic T1 and T2* measurement for AIF assessment combined with DCE MRI in a mouse tumor model. Magma 2007;20:193-203. (Pubitemid 350132158)
15. van der Schaaf I, Vonken EJ, Waaijer A, Velthuis B, Quist M, van Osch T. Influence of partial volume on venous output and arterial input function. AJNR Am J Neuroradiol 2006;27:46-50. (Pubitemid 46939882)
16. Chen JJ, Smith MR, Frayne R. Partial volume effect in quantitative magnetic resonance perfusion imaging. Conf Proc IEEE Eng Med Biol Soc 2004;2:1132-1135. (Pubitemid 40035983)
17. Wang J, Mao W, Qiu M, Smith MB, Constable RT. Factors influencing flip angle mapping in MRI: RF pulse shape, slice-select gradients, off-resonance excitation, and B0 inhomogeneities. Magn Reson Med 2006;56:463-468. (Pubitemid 44162796)
18. Warntjes JB, Dahlqvist O, Lundberg P. Novel method for rapid, simultaneous T1, T*2, and proton density quantification. Magn Reson Med 2007;57:528-537. (Pubitemid 46385863)
19. Wang J, Qiu M, Kim H, Constable RT. T1 measurements incorporating flip angle calibration and correction in vivo. J Magn Reson 2006;182:283-292. (Pubitemid 44466448)
20. Cheng HL, Wright GA. Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med 2006; 55:566-574.
21. Wen JG, Chen Y, Ringgaard S, et al. Evaluation of renal function in normal and hydronephrotic kidneys in rats using gadolinium diethylenetetramine- pentaacetic acid enhanced dynamic magnetic resonance imaging. J Urol 2000;163:1264-1270. (Pubitemid 30169422)
22. Jones RA, Easley K, Little SB, Scherz H, Kirsch AJ, Grattan-Smith JD. Dynamic contrast-enhanced MR urography in the evaluation of pediatric hydronephrosis. Part 1. Functional assessment. AJR Am J Roentgenol 2005;185:1598-1607.
23. Bokacheva L, Huang AJ, Chen Q, et al. Single breath-hold T1 measurement using low flip angle TrueFISP. Magn Reson Med 2006;55:1186-1190.
24. Parker GJ, Roberts C, Macdonald A, et al. Experimentally derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006;56:993-1000. (Pubitemid 44691341)
25. Le Sech C, Capderou A. Determination of pulmonary mean transit time and cardiac output using a one-dimensional model. Bull Math Biol 1996;58:1155-1170. (Pubitemid 27030011)
26. Reiser UJ. Study of bolus geometry after intravenous contrast medium injection: dynamic and quantitative measurements (Chronogram) using an X-ray CT device. J Comput Assist Tomogr 1984;8: 251-262.
27. Hany TF, McKinnon GC, Leung DA, Pfammatter T, Debatin JF. Optimization of contrast timing for breath-hold three-dimensional MR angiography. J Magn Reson Imaging 1997;7:551-556. (Pubitemid 28360874)
28. Boos M, Scheffler K, Haselhorst R, Reese E, Frohlich J, Bongartz GM. Arterial first pass gadolinium-CM dynamics as a function of several intravenous saline flush and Gd volumes. J Magn Reson Imaging 2001;13:568-576. (Pubitemid 32231511)
29. Kim S, Quon H, Loevner LA, et al. Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck. J Magn Reson Imaging 2007;26:1607-1617. (Pubitemid 350301150)
30. Zierler KL. Equations for measuring blood flow by external monitoring of radioisotopes. Circ Res 1965;16:309-321.
31. Millard RK. Indicator-dilution dispersion models and cardiac output computing methods. Am J Physiol 1997;272:H2004-2012.
32. Rebergen SA, van der Wall EE, Doornbos J, de Roos A. Magnetic resonance measurement of velocity and flow: technique, validation, and cardiovascular applications. Am Heart J 1993;126:1439-1456. (Pubitemid 24000041)
33. Berton C, Cholley B. Equipment review: new techniques for cardiac output measurement - oesophageal Doppler, Fick principle using carbon dioxide, and pulse contour analysis. Crit Care 2002;6:216-221.
34. Szolar DH, Sakuma H, Higgins CB. Cardiovascular applications of magnetic resonance flow and velocity measurements. J Magn Reson Imaging 1996;6:78-89. (Pubitemid 126702447)
35. Kuehne T, Yilmaz S, Schulze-Neick I, et al. Magnetic resonance imaging guided catheterisation for assessment of pulmonary vascular resistance: in vivo validation and clinical application in patients with pulmonary hypertension. Heart (British Cardiac Society) 2005;91:1064-1069. (Pubitemid 41060017)
36. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004;25:1940-1965.
37. Davenport R. The derivation of the gamma-variate relationship for tracer dilution curves. J Nucl Med 1983;24:945-948. (Pubitemid 14236778)
38. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology 1998;207:657-662.
39. Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? Pharmacokinetic study in a porcine model. Radiology 2003;227:809-816.
40. Stanisz GJ, Odrobina EE, Pun J, et al. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54: 507-512.
41. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40:715-724. (Pubitemid 41546838)
42. Cheng HL. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. J Magn Reson Imaging 2007;25:1073-1078.
43. Robert P, Violas X, Santus R, Le Bihan D, Corot C. Optimization of a blood pool contrast agent injection protocol for MR angiography. J Magn Reson Imaging 2005;21:611-619. (Pubitemid 40586761)
44. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
45. Padhani AR, Hayes C, Landau S, Leach MO. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 2002;15:143-153. (Pubitemid 34213404)
46. Stevenson JP, Rosen M, Sun W, et al. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol 2003;21:4428-4438. (Pubitemid 46621821)
47. Galbraith SM, Maxwell RJ, Lodge MA, et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol 2003;21:2831-2842.
48. Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002;15:154-163. (Pubitemid 34213405)
49. Rusinek H, Boykov Y, Kaur M, et al. Performance of an automated segmentation algorithm for 3D MR renography. Magn Reson Med 2007;57:1159-1167. (Pubitemid 46911299)
50. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230:652-659.
51. Bluml S, Schad LR, Stepanow B, Lorenz WJ. Spin-lattice relaxation time measurement by means of a TurboFLASH technique. Magn Reson Med 1993;30:289-295. (Pubitemid 23264606)
52. Zhang JL, Rusinek H, Bokacheva L, et al. Angiotensin-converting enzyme inhibitor-enhanced MR renography: repeated measures of GFR and RPF in hypertensive patients. Am J Physiol 2009;296: F884-891.
53. Taylor AT Jr, Fletcher JW, Nally JV Jr, et al. Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine. J Nucl Med 1998;39:1297-1302.
54. Brandfonbrener M, Landowne M, Shock NW. Changes in cardiac output with age. Circulation 1955;12:557-566.